Republicans on Thursday voted down a proposed amendment to the Farm Bill that would have protected consumer rights to sue pesticide manufacturers over alleged harm after the US Supreme Court recently narrowed those rights.
A former EPA chemist recounts agency reluctance to respond to risks seen with pesticides.
Several common pesticides, including the controversial herbicide glyphosate, cause genetic damage to people’s cells at very low exposure levels, according to a new study. Such cellular changes, often referred to as “genotoxicity,” are linked to cancer.
The US Supreme Court last week ruled in favor of the former Monsanto company in a closely watched case that limits people’s ability to sue pesticide companies for alleged illnesses or injuries. Editorial intern Julie Zenderoudi breaks it down.
Some US lawmakers are rushing to introduce legislation to reverse the impact of a US Supreme Court ruling handed down last week that overturned years of precedent by limiting consumer lawsuits against pesticide companies.
A day after landmark ruling from the US Supreme Court stripped consumers of a key pathway for suing pesticide companies, legal experts said while the decision is a blow for people who blame injuries on pesticide exposure, it’s not a knock-out punch.
The US Supreme Court on Thursday ruled in favor of the former Monsanto company in a closely watched case that limits people’s ability to sue pesticide companies for alleged illnesses or injuries. TNL editor-in-chief Carey Gillam talks to George Kimbrell of the Center for Food Safety about the decision.
The US Supreme Court has ruled in favor of the former Monsanto company in a closely watched case that limits people’s ability to sue pesticide companies for alleged illnesses or injuries.
A lawsuit filed by an environmental group is demanding answers after the USDA failed to turn over records related to an executive order issued by President Donald Trump protecting the production of glyphosate.
A federal judge has rejected efforts to slow the progress of a $7.25 billion class action settlement in the nationwide Roundup cancer litigation, notching a win for Roundup maker Bayer but frustrating a group of plaintiffs’ attorneys who claim the deal is unfair to cancer patients.